Health ❯ Healthcare

Medical Research

Cancer Research Clinical Trials Oncology Cancer Treatment Clinical Studies Neurology Genetics Pharmacology Cardiology Gene Therapy

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

Researchers are advancing randomized trials to determine whether the association reflects a true treatment benefit.

First Human Trial Finds Enteral Ventilation Procedure Tolerable in Healthy Volunteers

FDA Expands Revumenib Approval to NPM1-Mutant Relapsed/Refractory AML in Patients 1 and Older

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Live Imaging Study Questions IVF Embryo Screening as Placental Errors Emerge Late

At AAO, Prospective Study Backs Office-Based Cataract Surgery With Oral Sedation

Small Pediatric Study Links Pazopanib to Improved Two-Year Survival in Metastatic Ewing Sarcoma

Starting Estrogen in Perimenopause Linked to Lower Cancer and Cardiovascular Risks in Massive EHR Study

Long-Read Sequencing and 'LongTrack' Map Donor Bacteria After Fecal Transplants

Common Placental Biomarker Accurately Flags Early Preeclampsia Risk in Sickle Cell Pregnancies

Danaher Jumps After Q3 Beat on EPS and Revenue

Wireless Retinal Implant Restores Central Vision in Advanced AMD, NEJM Study Finds

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Ultrasound-Guided Botox Eases Phantom Limb Pain for Ukrainian Amputees, Study Finds

First Human-Model Test Shows Enzyme-Converted Kidney Can Function After Blood-Type Switch

OpenEvidence Raises $200 Million as Reports Put Valuation Between $6B and $6.5B

Digital Patient Outreach Raises Lung CT Screening to 24.5% in JAMA Trial

ctDNA-Guided Atezolizumab Extends Survival After Bladder Cancer Surgery in Phase III Trial

Final EMBARK Results Show 40% Lower Mortality With Enzalutamide Plus Leuprolide in High-Risk Recurrent Prostate Cancer

Padcev–Keytruda Cuts Recurrence and Death Risk in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer